Article Information
History
- May 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ayesha Appa, MD1,*,
- Gabriel Chamie, MD, MPH1,
- Aenor Sawyer, MD2,
- Kimberly Baltzell, RN, PhD, MS3,
- Kathryn Dippell, MSN, NP3,
- Salu Ribeiro, BS, MS4,
- Elias Duarte, BA1,
- Joanna Vinden, MPH1,
- Cliahub Consortium5,6,
- Jonathan Kramer-Feldman, BA4,
- Shahryar Rahdar, BS4,
- Doug MacIntosh, RN7,
- Katherine Nicholson, RN7,
- Jonathan Im, BA1,
- Diane Havlir, MD1 and
- Bryan Greenhouse, MD1,5
- 1University Of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine;
- 2University of California San Francisco Department of Orthopedic Surgery;
- 3University of California San Francisco School of Nursing;
- 4University of California San Francisco School of Medicine;
- 5Chan Zuckerberg Biohub;
- 6University of California San Francisco Department of Laboratory Medicine;
- 7San Francisco State University School of Nursing;
- 8University of California San Francisco School of Pharmacy
- ↵* Corresponding author; email: ayesha.appa{at}ucsf.edu
Posted May 30, 2020.
SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
